Tumor-derived exosomes enriched with miR-21, TGF-β, or PD-L1 deliver suppressive cues that favor Treg expansion, inhibit NK-cell cytotoxicity, and blunt CD8+ T cell activation. The gene discussed is TGFB1; the disease is neoplasm.